Biomedcode's human TNF transgenic arthritis model, (Tg197), contributes to the non-clinical assessment of etanercept biosimilar GP2015 with originator etanercept (Enbrel)


In the evaluation process of the proposed biosimilar to Enbrel, GP2015, non-clinical data using the Tg197 model of arthritis confirmed its comparability to the originator with regards to its pharmacokinetic properties, pharmacodynamic activity, efficacy and safety/toxicity.

Read more >


Return to News